In response to pleas by Amway, Modicare and Oriflame, India’s Delhi High Court has restrained e-commerce companies such as Amazon, Flipkart and Snapdeal from selling the products of these direct sellers without their consent in India. The three direct sellers reported that their branded products were not only being sold at cheaper rates on the e-commerce platforms resulting in financial loss, but may have been tampered with or counterfeited. Further inspection of products on order of the court did find labeling, codes and manufacturing dates to have been changed, and the court stated the obligation of the companies to maintain security and quality standards of products and sellers. Justice Pratibha M Singhalso reiterated that the platforms had failed in adherence to their own policies of conduct.
Delhi’s High Court Restricts Sales of DS Products on Amazon
